India inspects drug factories as Gambia controversy lingersBusiness, Health, TherapeuticsIndia’s pharmaceuticals regulator has begun inspecting some drug factories across the country, the health ministry said on Tuesday, as it tries to ensure high standards after an Indian company’s cough and cold syrups were linked to deaths in Gambia. Read more December 27, 2022/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2022/10/Reuterscoughsyrup10-20-2022.jpg 841 1200 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2022-12-27 06:49:402022-12-27 11:02:06India inspects drug factories as Gambia controversy lingers